Document is current
Any future updates will be listed below
-
Authors
Rapoport, Alan M.
Bonner, Jo H.
Lin, Tamar
Harris, Dagan
Gruper, Yaron
Ironi, Alon
Cowan, Robert P.
-
Funding
Funding for this research was provided by:
Theranica Bio-Electronics
- License Information
-
More Information
Article History
Received: 6 May 2019
Accepted: 5 July 2019
First Online: 22 July 2019
Ethics approval and consent to participate
: The study protocol was reviewed and approved by the appropriate institutional review board for each site and was conducted according to Good Clinical Practice and the Declaration of Helsinki guidelines. Before undergoing any study procedures, patients provided written informed consent.
: Not applicable.
: Alan Rapoport serves as an advisor for Amgen, Amneal, Automatic Technologies, Neurolief, Promius, Satsuma, Teva Pharmaceutical Industries, Theranica, and Zosano; and is on the speakers’ bureau of Amgen, Electrocore, Promius, and Teva Pharmaceutical Industries, Jo Bonner declares no competing interests. Tamar Lin, Dagan Harris, Yaron Gruper and Alon Ironi are employees of Theranica Ltd. Robert Cowan serves as a consultant and/or on the Advisory Board for Alder, Allergan, Amgen, Biohaven, Electrocore, Impel, Lilly, Novartis, Satsuma, Supernus, Teva, Theranica, Xoc and Zosano; receives royalties from Penguin/Avery, Oxford University Press, and Springer; and is founder and principle in BonTriage, Inc. and ProMyHealth, LLC.
